Since its inception in 1999 BioPartnering has grown to become the largest, most authoritative cluster of services of its type in the world. Silico has recently announced the launch of the new configuration of BioPartnering.
BioPartnering is relied upon by many of the largest pharmaceutical and biotechnology companies in the world to understand their reputational strengths and weaknesses and as a company that people 'want to do business with'.
Expanded and extensively redesigned, BioPartnering that consists of a cluster of services that, together, provide the most comprehensive source of insight into the current state of strategic alliances and collaborations and business development in the biopharmaceutical sector available today.
BioPartnering currently includes three core Programmes: (click on the links to find out more about each Programme):
The underlying data in the component programmes will be updated on a regular basis to ensure that it provides an up-to-date assessment of the current sentiment about the issues addressed by the service. Contact us for more information about this service.